# Cigna Group: financial statements, quarterly

CI · NYSE · CIK 1739940 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ci.md) · [Financials](/companies/ci/financials.md) · [Filings](/companies/ci/filings.md) · [Insiders](/companies/ci/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ci/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [49.0](/filings/0001739940-24-000033.md) | [51.1 d](/filings/0001739940-26-000006.md) | [57.3](/filings/0001739940-25-000021.md) | [60.5](/filings/0001739940-25-000028.md) | [63.7](/filings/0001739940-25-000037.md) | [65.6 d](/filings/0001739940-26-000006.md) | [65.5](/filings/0001739940-26-000043.md) | [67.2](/filings/0001739940-26-000065.md) | [69.7](/filings/0001739940-25-000037.md) | [72.5 d](/filings/0001739940-26-000006.md) | [68.5](/filings/0001739940-26-000043.md) | [71.7](/filings/0001739940-26-000065.md) |
| Cost of revenue | $bn | [33.6](/filings/0001739940-24-000033.md) | [35.3 d](/filings/0001739940-26-000006.md) | [41.4](/filings/0001739940-25-000021.md) | [44.5](/filings/0001739940-25-000028.md) | [47.6](/filings/0001739940-25-000037.md) | [49.0 d](/filings/0001739940-26-000006.md) | [48.4](/filings/0001739940-26-000043.md) | [53.3](/filings/0001739940-26-000065.md) | [55.5](/filings/0001739940-25-000037.md) | [57.8 d](/filings/0001739940-26-000006.md) | [54.1](/filings/0001739940-26-000043.md) | [56.7](/filings/0001739940-26-000065.md) |
| Selling, general and administrative | $bn | [3.8](/filings/0001739940-24-000033.md) | [4.1 d](/filings/0001739940-26-000006.md) | [3.7](/filings/0001739940-25-000021.md) | [3.7](/filings/0001739940-25-000028.md) | [3.6](/filings/0001739940-25-000037.md) | [3.9 d](/filings/0001739940-26-000006.md) | [4.2](/filings/0001739940-26-000043.md) | [3.4](/filings/0001739940-26-000065.md) | [3.4](/filings/0001739940-25-000037.md) | [3.6 d](/filings/0001739940-26-000006.md) | [3.7](/filings/0001739940-26-000043.md) | [3.5](/filings/0001739940-26-000065.md) |
| Operating income | $bn | [2.2](/filings/0001739940-24-000033.md) | [2.1 d](/filings/0001739940-26-000006.md) | [2.3](/filings/0001739940-25-000021.md) | [2.4](/filings/0001739940-25-000028.md) | [2.6](/filings/0001739940-25-000037.md) | [2.2 d](/filings/0001739940-26-000006.md) | [2.0](/filings/0001739940-26-000043.md) | [2.3](/filings/0001739940-26-000065.md) | [2.6](/filings/0001739940-25-000037.md) | [2.3 d](/filings/0001739940-26-000006.md) | [2.4](/filings/0001739940-26-000043.md) | [2.7](/filings/0001739940-26-000065.md) |
| Income tax | $bn | [0.4](/filings/0001739940-24-000033.md) | [(0.9) d](/filings/0001739940-26-000006.md) | [0.3](/filings/0001739940-25-000021.md) | [0.4](/filings/0001739940-25-000028.md) | [0.4](/filings/0001739940-25-000037.md) | [0.5 d](/filings/0001739940-26-000006.md) | [0.2](/filings/0001739940-26-000043.md) | [0.4](/filings/0001739940-26-000065.md) | [0.3](/filings/0001739940-25-000037.md) | [0.5 d](/filings/0001739940-26-000006.md) | [0.4](/filings/0001739940-26-000043.md) | [0.4](/filings/0001739940-26-000065.md) |
| Net income | $bn | [1.4](/filings/0001739940-24-000033.md) | [0.9 d](/filings/0001739940-26-000006.md) | [(0.2)](/filings/0001739940-25-000021.md) | [1.6](/filings/0001739940-25-000028.md) | [0.8](/filings/0001739940-25-000037.md) | [1.2 d](/filings/0001739940-26-000006.md) | [1.3](/filings/0001739940-26-000043.md) | [1.5](/filings/0001739940-26-000065.md) | [2.0](/filings/0001739940-25-000037.md) | [0.9 d](/filings/0001739940-26-000006.md) | [1.7](/filings/0001739940-26-000043.md) | [1.7](/filings/0001739940-26-000065.md) |
| Diluted EPS | $ per share | [4.74](/filings/0001739940-24-000033.md) | not reported | [(0.97)](/filings/0001739940-25-000021.md) | [5.45](/filings/0001739940-25-000028.md) | [2.63](/filings/0001739940-25-000037.md) | not reported | [4.85](/filings/0001739940-26-000043.md) | [5.71](/filings/0001739940-26-000065.md) | [6.98](/filings/0001739940-25-000037.md) | not reported | [6.26](/filings/0001739940-26-000043.md) | [6.29](/filings/0001739940-26-000065.md) |
| Basic EPS | $ per share | [4.79](/filings/0001739940-24-000033.md) | not reported | [(0.97)](/filings/0001739940-25-000021.md) | [5.51](/filings/0001739940-25-000028.md) | [2.65](/filings/0001739940-25-000037.md) | not reported | [4.88](/filings/0001739940-26-000043.md) | [5.76](/filings/0001739940-26-000065.md) | [7.02](/filings/0001739940-25-000037.md) | not reported | [6.30](/filings/0001739940-26-000043.md) | [6.31](/filings/0001739940-26-000065.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [8.5](/filings/0001739940-23-000025.md) | [7.8](/filings/0001739940-25-000009.md) | [8.4](/filings/0001739940-24-000015.md) | [6.8](/filings/0001739940-24-000028.md) | [5.9](/filings/0001739940-24-000033.md) | [7.6](/filings/0001739940-26-000006.md) | [8.3](/filings/0001739940-25-000021.md) | [4.3](/filings/0001739940-25-000028.md) | [6.0](/filings/0001739940-25-000037.md) | [7.7](/filings/0001739940-26-000065.md) | [7.0](/filings/0001739940-26-000043.md) | [6.3](/filings/0001739940-26-000065.md) |
| Current assets | $bn | [34.5](/filings/0001739940-23-000025.md) | [37.4](/filings/0001739940-25-000009.md) | [43.4](/filings/0001739940-24-000015.md) | [46.2](/filings/0001739940-24-000028.md) | [49.2](/filings/0001739940-24-000033.md) | [48.9](/filings/0001739940-26-000006.md) | [43.6](/filings/0001739940-25-000021.md) | [44.7](/filings/0001739940-25-000028.md) | [46.7](/filings/0001739940-25-000037.md) | [47.8](/filings/0001739940-26-000065.md) | [43.0](/filings/0001739940-26-000043.md) | [47.0](/filings/0001739940-26-000065.md) |
| Total assets | $bn | [150](/filings/0001739940-23-000025.md) | [153](/filings/0001739940-25-000009.md) | [153](/filings/0001739940-24-000015.md) | [155](/filings/0001739940-24-000028.md) | [158](/filings/0001739940-24-000033.md) | [156](/filings/0001739940-26-000006.md) | [151](/filings/0001739940-25-000021.md) | [152](/filings/0001739940-25-000028.md) | [158](/filings/0001739940-25-000037.md) | [158](/filings/0001739940-26-000065.md) | [153](/filings/0001739940-26-000043.md) | [157](/filings/0001739940-26-000065.md) |
| Current liabilities | $bn | [47.1](/filings/0001739940-23-000025.md) | [48.7](/filings/0001739940-25-000009.md) | [52.0](/filings/0001739940-24-000015.md) | [55.4](/filings/0001739940-24-000028.md) | [57.1](/filings/0001739940-24-000033.md) | [58.0](/filings/0001739940-26-000006.md) | [55.7](/filings/0001739940-25-000021.md) | [56.8](/filings/0001739940-25-000028.md) | [56.5](/filings/0001739940-25-000037.md) | [56.3](/filings/0001739940-26-000065.md) | [52.6](/filings/0001739940-26-000043.md) | [55.6](/filings/0001739940-26-000065.md) |
| Total liabilities | $bn | [104](/filings/0001739940-23-000025.md) | [106](/filings/0001739940-25-000009.md) | [112](/filings/0001739940-24-000015.md) | [114](/filings/0001739940-24-000028.md) | [115](/filings/0001739940-24-000033.md) | [115](/filings/0001739940-26-000006.md) | [110](/filings/0001739940-25-000021.md) | [111](/filings/0001739940-25-000028.md) | [116](/filings/0001739940-25-000037.md) | [116](/filings/0001739940-26-000065.md) | [111](/filings/0001739940-26-000043.md) | [114](/filings/0001739940-26-000065.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [3.0](/filings/0001739940-23-000025.md) | [2.8](/filings/0001739940-25-000009.md) | [1.7](/filings/0001739940-24-000015.md) | [1.7](/filings/0001739940-24-000028.md) | [2.6](/filings/0001739940-24-000033.md) | [3.0](/filings/0001739940-26-000006.md) | [4.0](/filings/0001739940-25-000021.md) | [4.3](/filings/0001739940-25-000028.md) | [3.1](/filings/0001739940-25-000037.md) | [0.6](/filings/0001739940-26-000065.md) | [1.5](/filings/0001739940-26-000043.md) | [2.8](/filings/0001739940-26-000065.md) |
| Short-term borrowings | $bn | [1.5](/filings/0001739940-23-000025.md) | [1.2](/filings/0001739940-25-000009.md) | [0.9](/filings/0001739940-24-000015.md) | [0.8](/filings/0001739940-24-000028.md) | [1.6](/filings/0001739940-24-000033.md) | [0.9](/filings/0001739940-26-000006.md) | [0.0](/filings/0001739940-25-000021.md) | not reported | not reported | [0.0](/filings/0001739940-26-000006.md) | not reported | [1.0](/filings/0001739940-26-000065.md) |
| Shareholders' equity | $bn | [45.7](/filings/0001739940-23-000025.md) | [46.2](/filings/0001739940-25-000009.md) | [41.2](/filings/0001739940-24-000015.md) | [41.3](/filings/0001739940-24-000028.md) | [42.1](/filings/0001739940-24-000033.md) | [41.0](/filings/0001739940-26-000006.md) | [40.2](/filings/0001739940-25-000021.md) | [40.2](/filings/0001739940-25-000028.md) | [41.8](/filings/0001739940-25-000037.md) | [41.7](/filings/0001739940-26-000065.md) | [42.2](/filings/0001739940-26-000043.md) | [42.6](/filings/0001739940-26-000065.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,826 d](/filings/0001739940-24-000033.md) | [1,467 d](/filings/0001739940-26-000006.md) | [4,840](/filings/0001739940-25-000021.md) | [265 d](/filings/0001739940-25-000028.md) | [46.0 d](/filings/0001739940-25-000037.md) | [5,212 d](/filings/0001739940-26-000006.md) | [1,920](/filings/0001739940-26-000043.md) | [(1,886) d](/filings/0001739940-26-000065.md) | [3,418 d](/filings/0001739940-25-000037.md) | [6,149 d](/filings/0001739940-26-000006.md) | [1,131](/filings/0001739940-26-000043.md) | [(421) d](/filings/0001739940-26-000065.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [362 d](/filings/0001739940-24-000033.md) | [358 d](/filings/0001739940-26-000006.md) | [401](/filings/0001739940-25-000021.md) | [392 d](/filings/0001739940-25-000028.md) | [390 d](/filings/0001739940-25-000037.md) | [384 d](/filings/0001739940-26-000006.md) | [412](/filings/0001739940-26-000043.md) | [401 d](/filings/0001739940-26-000065.md) | [402 d](/filings/0001739940-25-000037.md) | [396 d](/filings/0001739940-26-000006.md) | [417](/filings/0001739940-26-000043.md) | [409 d](/filings/0001739940-26-000065.md) |
| Share repurchases | $m | [624 d](/filings/0001739940-24-000033.md) | [544 d](/filings/0001739940-26-000006.md) | [4,022](/filings/0001739940-25-000021.md) | [990 d](/filings/0001739940-25-000028.md) | [0.0 d](/filings/0001739940-25-000037.md) | [2,022 d](/filings/0001739940-26-000006.md) | [1,508](/filings/0001739940-26-000043.md) | [1,112 d](/filings/0001739940-26-000065.md) | [0.0 d](/filings/0001739940-25-000037.md) | [1,001 d](/filings/0001739940-26-000006.md) | [0.0](/filings/0001739940-26-000043.md) | [280 d](/filings/0001739940-26-000065.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [308](/filings/0001739940-23-000025.md) | [299](/filings/0001739940-24-000015.md) | [297](/filings/0001739940-24-000028.md) | [297](/filings/0001739940-24-000033.md) | [286](/filings/0001739940-25-000021.md) | [284](/filings/0001739940-25-000028.md) | [281](/filings/0001739940-25-000037.md) | [273](/filings/0001739940-26-000043.md) | [268](/filings/0001739940-26-000065.md) | [268](/filings/0001739940-25-000037.md) | [264](/filings/0001739940-26-000043.md) | [264](/filings/0001739940-26-000065.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 264,240,486 at 2026-07-24, from the cover of the [10-Q filed 2026-07-30](/filings/0001739940-26-000065.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.